Hypokalemia Management

Admitting Criteria

Patients with hypokalemia (serum potassium <3.5 mEq/L) should be admitted for monitoring and treatment when levels are ≤2.0 mEq/L or when associated with cardiac or neuromuscular symptoms, as these represent potentially unstable metabolic conditions requiring multiple disciplinary intervention and frequent monitoring 1, 2
Admit to telemetry unit for patients with moderate hypokalemia (K+ 2.5-2.9 mEq/L) or severe hypokalemia (K+ <2.5 mEq/L) due to risk of cardiac arrhythmias 3
Consider ICU admission for severe hypokalemia (K+ <2.0 mEq/L) or patients with ECG changes, neuromuscular symptoms, or hemodynamic instability 2, 4

Continuous cardiac monitoring for moderate to severe hypokalemia (K+ <3.0 mEq/L) 3
Daily weights 5
Target serum potassium in the 4.0-5.0 mEq/L range, with closer to 4.5-5.0 mEq/L for cardiac patients 4
Correct hypomagnesemia if present (IV magnesium sulfate) 3, 4

Baseline labs: Complete metabolic panel, magnesium, phosphorus, CBC 4
ECG on admission and after potassium correction 3
Serum potassium every 4-6 hours during IV replacement, then daily until stable 4
Magnesium level (hypomagnesemia can make hypokalemia resistant to correction) 3, 4

Oral potassium chloride 20-60 mEq/day for mild hypokalemia or maintenance after IV correction 4
Consider potassium-sparing diuretics (spironolactone 25-100 mg daily, amiloride 5-10 mg daily, or triamterene 50-100 mg daily) for patients with persistent diuretic-induced hypokalemia 4
Hold medications that worsen hypokalemia (thiazide/loop diuretics, amphotericin B, etc.) 4
If digoxin is being used, monitor closely as hypokalemia increases risk of digoxin toxicity 4